The FDA approved Addyi (flibanserin), a libido-enhancing drug, in postmenopausal women under the age of 65. Experts explain ...

The FDA expanded its approval of Addyi to treat low libido in postmenopausal women up to age 65. The approval will open up ...

Pregnancy, menopause and hormone therapy may all impact a woman’s lipoprotein(a) level, challenging the mantra of the once-in ...

An FDA panel of experts has called for a loosening of regulations and expanding access to testosterone replacement therapy.

On Dec. 15, Sprout Pharmaceuticals received approval to use its pill, Addyi (flibanserin), to treat low sexual desire in ...

The "little pink pill" is now available to even more women. The Food and Drug Administration (FDA) just approved Addyi for ...

U.S. health officials have expanded approval of a much-debated drug aimed at boosting female libido, saying the once-a-day pill can now be taken by women older than 65.

1 Department of Endocrinology, The Second Affiliated Hospital and Yuying Children’s Hospital of Wenzhou Medical University, Wenzhou, China 2 Department of Cardiology, The Second Affiliated Hospital ...

NPR's Steve Inskeep speaks with FDA Commissioner Martin Makary about the decline in testosterone in men in the U.S. and what ...

Cycle, Dosage, Side Effects, Most Popular Legal Steroids (Before And After Anavar Result) - Anavar for women (Anavar for Sale ...

Testosterone is one of the few hormones that’s broken out of biology textbooks and into the popular consciousness. For years it has been a shorthand for all things stereotypically male—ever notice how ...

Indianapolis features “arguably, the largest group of female leaders holding elite sports roles in one city in the nation,” as 10 women sit at the helm of some of the city’s highest-ranking sports ...